Development and validation of the novel recurrence risk stratification for initial non-muscle invasive bladder cancer
Not Applicable
- Conditions
- non-muscle invasive bladder cancer
- Registration Number
- JPRN-UMIN000021878
- Lead Sponsor
- Juntendo University, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 856
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with any of the following were excluded from this analysis: (i) non-Urothelial carcinoma histology, (ii) follow-up periods < 3 months: (iii) history of muscle-invasive or metastatic bladder cancer; (iv) history of carcinoma of the urethra, prostate (ducts or stroma), or upper urinary tract; (v) history of local radiation therapy to the pelvis; (vi) history of every kind of chemotherapy; (vii) history of previous bacillus Calmette-Guerin (BCG) therapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence free survival rate
- Secondary Outcome Measures
Name Time Method Progression disease, and death of bladder cancer